201 related articles for article (PubMed ID: 35262275)
1. The Paris system classification for urinary cytology in patients under bacillus Calmette-Guerin treatment.
Moulavasilis N; Stravodimos K; Meletis E; Levis P; Leftheriotis V; Lazaris A; Constantinides C; Mikou P
Diagn Cytopathol; 2022 Jun; 50(6):289-294. PubMed ID: 35262275
[TBL] [Abstract][Full Text] [Related]
2. Application of the Paris Reporting System for Urine Cytology: The Three-Year Experience of a Single Tertiary Care Institute in Thailand.
Phruttinarakorn B; Plumworasawat S; Kayankarnnavee J; Lualon J; Pongtippan A
Acta Cytol; 2022; 66(2):134-141. PubMed ID: 34999581
[TBL] [Abstract][Full Text] [Related]
3. Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology.
Miyai K; Nakayama M; Minabe S; Ogata S; Ito K; Matsukuma S
Cancer Cytopathol; 2024 Apr; 132(4):242-249. PubMed ID: 38294961
[TBL] [Abstract][Full Text] [Related]
4. Impact of bacillus Calmette-Guerin intravesical therapy on the diagnostic efficacy of The Paris System for Reporting Urinary Cytology in patients with high-grade bladder cancer.
Hermans J; Jokisch F; Volz Y; Eismann L; Pfitzinger P; Ebner B; Weinhold P; Schlenker B; Stief CG; Tritschler S; Schulz GB
Cancer Cytopathol; 2022 Apr; 130(4):294-302. PubMed ID: 34919338
[TBL] [Abstract][Full Text] [Related]
5. Atypical Category of the Johns Hopkins Template Has Higher Risk of Malignancy than the Paris System but the Paris System Is More Applicable for Suspicious Category.
Celik B; Kavas G
Acta Cytol; 2023; 67(4):425-433. PubMed ID: 36731438
[TBL] [Abstract][Full Text] [Related]
6. [Practical application of the Paris system for reporting urinary cytology].
Chen L; Liu LT; Sun MJ; He SR; Liu DG
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):470-476. PubMed ID: 38678328
[No Abstract] [Full Text] [Related]
7. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.
Khajir G; Sun T; Wang H; Sprenkle PC; Adeniran AJ; Cai G; Levi AW
Cytopathology; 2024 Mar; 35(2):235-241. PubMed ID: 37916579
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Implementation and Diagnostic Accuracy of the Paris Classification for Reporting Urinary Cytology in Voided Urine Specimens: A Cyto-Histological Correlation Study in a Cancer Center.
Lobo J; Lobo C; Leça L; Rodrigues Â; Henrique R; Monteiro P
Pathobiology; 2023; 90(4):233-240. PubMed ID: 36574757
[TBL] [Abstract][Full Text] [Related]
9. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature.
Pastorello RG; Barkan GA; Saieg M
J Am Soc Cytopathol; 2021; 10(1):79-87. PubMed ID: 33160893
[TBL] [Abstract][Full Text] [Related]
10. Comparison of conventional and liquid-based cytology using The Paris System for Reporting Urinary Cytology.
Goutas D; Savvidou K; Vrettou K; Meletis E; Levis P; Constantinides C; Lazaris AC; Mikou P
Cytopathology; 2021 Nov; 32(6):795-801. PubMed ID: 34289188
[TBL] [Abstract][Full Text] [Related]
11. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.
Vlajnic T; Gut A; Savic S; Bubendorf L
J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041
[TBL] [Abstract][Full Text] [Related]
12. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
[TBL] [Abstract][Full Text] [Related]
13. Clinical follow up and the impact of the Paris system in the assessment of patients with atypical urine cytology.
Northrup V; Acar BC; Hossain M; Acker MR; Manuel E; Rahmeh T
Diagn Cytopathol; 2018 Dec; 46(12):1022-1030. PubMed ID: 30375194
[TBL] [Abstract][Full Text] [Related]
14. Should "suspicious for high-grade urothelial carcinoma" and "positive for high-grade urothelial carcinoma" remain separate categories?
Nguyen L; Nilforoushan N; Krane JF; Bose S; Bakkar R
Cancer Cytopathol; 2021 Feb; 129(2):156-163. PubMed ID: 33036060
[TBL] [Abstract][Full Text] [Related]
15. Methylation study of the Paris system for reporting urinary (TPS) categories.
Pierconti F; Martini M; Cenci T; Fiorentino V; Sacco E; Bientinesi R; Pugliese D; Iacovelli R; Schinzari G; Larocca LM; Bassi PF
J Clin Pathol; 2021 Feb; 74(2):102-105. PubMed ID: 32527754
[TBL] [Abstract][Full Text] [Related]
16. The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?
Pierconti F; Martini M; Fiorentino V; Cenci T; Capodimonti S; Straccia P; Sacco E; Pugliese D; Cindolo L; Larocca LM; Bassi PF
Urol Oncol; 2021 Feb; 39(2):131.e17-131.e21. PubMed ID: 32773233
[TBL] [Abstract][Full Text] [Related]
17. The Paris System for reporting urinary cytology improves the negative predictive value of high-grade urothelial carcinoma.
Yamasaki M; Taoka R; Katakura K; Matsunaga T; Kani N; Honda T; Harada S; Tohi Y; Matsuoka Y; Kato T; Okazoe H; Tsunemori H; Ueda N; Haba R; Sugimoto M
BMC Urol; 2022 Apr; 22(1):51. PubMed ID: 35382830
[TBL] [Abstract][Full Text] [Related]
18. Cyto-histo correlation and false-negative urine: Before and after the Paris system for reporting urinary cytology.
Yuan L; Gero M; Zia S; Aryal SC; Shetty S; Reynolds JP
Diagn Cytopathol; 2022 Aug; 50(8):404-410. PubMed ID: 35652594
[TBL] [Abstract][Full Text] [Related]
19. Utility of the Paris System in Urine Cytology for Improved Screening of High-Grade Urothelial Carcinoma in Bahrain.
Mahmoud Daoud R; Ali AH; Salim Fredericks S; Daoud S; Gomaa HR; AlHashimi FS
Cureus; 2024 Mar; 16(3):e57189. PubMed ID: 38681345
[TBL] [Abstract][Full Text] [Related]
20. Are we on track for diagnosing high-grade urothelial carcinoma with a minimum quantity of five malignant cells in lower tract specimens? Critical analysis of The Paris System Quantitation Criteria.
Folarin OS; Siddiqui MT
Cancer Cytopathol; 2023 Nov; 131(11):708-715. PubMed ID: 37572083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
